Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Respiratory and ...

Patients with severe COVID-19 who require venovenous extracorporeal membrane oxygenation (VV-ECMO) support can, if carefully selected and managed, obtain “exceptional survival” approaching 87% at 1 ...

Some patients with severe COVID-19 who are treated with extracorporeal membrane oxygenation (ECMO) may experience significant lung recovery and return to normal lives with 'meaningful' long-term ...

Packed red blood cell transfusion improved survival among adults with acute respiratory distress syndrome on venovenous extracorporeal membrane oxygenation when using a hemoglobin threshold of less ...

A notable proportion of patients receiving veno-venous extracorporeal membrane oxygenation (ECMO) for acute respiratory failure developed acute kidney injury (AKI), likely due to the greater severity ...

Patients with severe Covid-19, if treated with extracorporeal membrane oxygenation (ECMO), may see a major improvement in lung recovery, making their return to normal lives much faster, a study, ...

The pneumonia presented with the novel coronavirus disease 2019 can lead to severe respiratory failure with profound hypoxemia that requires endotracheal intubation and mechanical ventilation.

Please provide your email address to receive an email when new articles are posted on . A high effort to eliminate carbon dioxide was linked to a greater likelihood of failing to wean from venovenous ...

To describe the use of double-lumen venovenous (VVDL) extracorporeal membrane oxygenation (ECMO) with cephalic draining cannula (VVDL+V) as a primary approach for all neonatal respiratory diagnoses ...

Many extracorporeal membrane oxygenation (ECMO) patients experienced long-term neuropsychiatric symptoms, cognitive impairment, or functional impairment, a meta-analysis found. Fully 41% of ECMO ...